SGHT
Sight Sciences Inc
NASDAQ: SGHT · HEALTHCARE · MEDICAL DEVICES
$4.09
+3.02% today
Updated 2026-04-30
Market cap
$237.20M
P/E ratio
—
P/S ratio
3.07x
EPS (TTM)
$-0.74
Dividend yield
—
52W range
$3 – $9
Volume
0.4M
Sight Sciences Inc (SGHT) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
| Total assets | $8.09M | $30.74M | $72.81M | $280.19M | $213.07M | $166.65M | $142.84M |
| Cash & equivalents | $4.24M | $21.24M | $61.51M | $260.69M | $185.00M | $138.13M | $120.36M |
| Current assets | $7.16M | $28.00M | $70.63M | $277.04M | $209.68M | $162.87M | $139.77M |
| Total liabilities | $37.06M | $85.42M | $161.66M | $48.08M | $53.00M | $46.44M | $55.32M |
| Current liabilities | $2.90M | $7.34M | $9.31M | $13.50M | $17.82M | $12.25M | $15.47M |
| Long-term debt | — | $12.86M | $31.95M | $32.66M | $33.31M | $31.71M | $39.36M |
| Shareholder equity | $-28.96M | $-54.68M | $-88.85M | $232.11M | $160.08M | $120.22M | $87.52M |
| Retained earnings | $-29.48M | $-55.35M | $-90.04M | $-153.00M | $-239.24M | $-294.79M | $-346.30M |
| Accounts receivable | $1.81M | $4.09M | $5.36M | $8.71M | $15.15M | $14.29M | $10.79M |
| Inventory | $486000.00 | $2.24M | $2.60M | $3.48M | $6.11M | $7.85M | $6.33M |
| Goodwill | — | — | — | — | — | — | — |